Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Jaen

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|September 1, 1991
Dopamine autoreceptor agonists as potential antipsychotics. 3.6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amineB W Caprathe, J C Jaen, L D Wise, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Identification and characterization of m4 selective muscarinic antagonistsC E Augelli-Szafran, J C Jaen, D W Moreland, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
Novel halogenated sulfonamides inhibit the growth of multidrug resistant MCF-7/ADR cancer cellsJ C Medina, D Roche, B Shan, et al.
Journal of Medicinal Chemistry|January 1, 1990
Synthesis and dopamine agonist properties of (+-)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano [4,3-b]-1,4-oxazin-9-ol and its enantiomersH A DeWald, T G Heffner, J C Jaen, et al.
Journal of Medicinal Chemistry|October 19, 2001
Hydrophilic, pro-drug analogues of T138067 are efficacious in controlling tumor growth in vivo and show a decreased ability to cross the blood brain barrierS M Rubenstein, V Baichwal, H Beckmann, et al.
Journal of Medicinal Chemistry|January 1, 1990
4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist propertiesJ C Jaen, L D Wise, B W Caprathe, et al.
Journal of Medicinal Chemistry|February 13, 1999
Identification and characterization of m1 selective muscarinic receptor antagonists1C E Augelli-Szafran, C J Blankley, J C Jaen, et al.
Journal of Medicinal Chemistry|October 27, 1995
Kynurenic acid derivatives inhibit the binding of nerve growth factor (NGF) to the low-affinity p75 NGF receptorJ C Jaen, E Laborde, R A Bucsh, et al.
Journal of Medicinal Chemistry|August 2, 1996
Aryl 1-but-3-ynyl-4-phenyl-1,2,3,6-tetrahydropyridines as potential antipsychotic agents: synthesis and structure-activity relationshipsS A Glase, H C Akunne, T G Heffner, et al.
Journal of Medicinal Chemistry|October 14, 1994
The discovery and structure-activity relationships of 1,2,3,6-tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine autoreceptor agonists and potential antipsychotic agentsJ L Wright, B W Caprathe, D M Downing, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|September 1, 1991
Dopamine autoreceptor agonists as potential antipsychotics. 3.6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amineB W Caprathe, J C Jaen, L D Wise, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Identification and characterization of m4 selective muscarinic antagonistsC E Augelli-Szafran, J C Jaen, D W Moreland, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
Novel halogenated sulfonamides inhibit the growth of multidrug resistant MCF-7/ADR cancer cellsJ C Medina, D Roche, B Shan, et al.
Journal of Medicinal Chemistry|January 1, 1990
Synthesis and dopamine agonist properties of (+-)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano [4,3-b]-1,4-oxazin-9-ol and its enantiomersH A DeWald, T G Heffner, J C Jaen, et al.
Journal of Medicinal Chemistry|October 19, 2001
Hydrophilic, pro-drug analogues of T138067 are efficacious in controlling tumor growth in vivo and show a decreased ability to cross the blood brain barrierS M Rubenstein, V Baichwal, H Beckmann, et al.
Journal of Medicinal Chemistry|January 1, 1990
4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist propertiesJ C Jaen, L D Wise, B W Caprathe, et al.
Journal of Medicinal Chemistry|February 13, 1999
Identification and characterization of m1 selective muscarinic receptor antagonists1C E Augelli-Szafran, C J Blankley, J C Jaen, et al.
Journal of Medicinal Chemistry|October 27, 1995
Kynurenic acid derivatives inhibit the binding of nerve growth factor (NGF) to the low-affinity p75 NGF receptorJ C Jaen, E Laborde, R A Bucsh, et al.
Journal of Medicinal Chemistry|August 2, 1996
Aryl 1-but-3-ynyl-4-phenyl-1,2,3,6-tetrahydropyridines as potential antipsychotic agents: synthesis and structure-activity relationshipsS A Glase, H C Akunne, T G Heffner, et al.
Journal of Medicinal Chemistry|October 14, 1994
The discovery and structure-activity relationships of 1,2,3,6-tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine autoreceptor agonists and potential antipsychotic agentsJ L Wright, B W Caprathe, D M Downing, et al.
Pageof 3